Jointown Pharmaceutical Group Co., Ltd. Class ASSE: 600998

"Jointown Pharmaceutical Group Co., Ltd."Announcement on Outline of the 2026 Semi-annual Performance Briefing

Sep 3, 2026 · Issued by Jointown Pharmaceutical Group Co., Ltd. Class A via Shanghai Stock Exchange

Announcement on Outline of the 2026 Semi-annual Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Jointown Pharmaceutical Group Co., Ltd. Class A

"Jointown Pharmaceutical Group Co., Ltd."Announcement on Resolutions of the 24th Meeting of the 6th Board of DirectorsSep 1
"Jointown Pharmaceutical Group Co., Ltd."Announcement on Winning of a Bid by a Controlled Subsidiary for the County-level Medical Community Information Integration Construction ProjectAug 29
"Jointown Pharmaceutical Group Co., Ltd."Announcement on Issuance of the Second Tranche of Asset-backed Commercial Paper for 2026 (Supporting the Elderly Care Industry) and Related Party TransactionsAug 28
"Jointown Pharmaceutical Group Co., Ltd."Semi-annual Report for 2026Aug 25

All Jointown Pharmaceutical Group Co., Ltd. Class A news releases